Treatments

WHO releases strategy paper on COVID disease management and long-term disease prevention

Thu, 2023-05-04 10:55 — mike kraft

From emergency response to long-term COVID-19 disease management: sustaining gains made during the COVID-19 pandemic The updated two-year strategy builds on the objectives of the 2022 SPRP and supports countries as they are working to transition their critical emergency response activities to longer-term sustained COVID-19 disease prevention, control and management.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about WHO releases strategy paper on COVID disease management and long-term disease prevention
Log in or register to post comments

Overview of how the end of the national Covid emergency will affect Americans

Thu, 2023-05-04 10:35 — mike kraft

What the end of the covid public health emergency means for you Here’s how major health policies will be affected when the covid public health emergency ends on on May 11. Washington Post

...

As this long emergency period expires, experts say, the biggest impact for consumers will be the end of free coronavirus tests — both at-home tests and those performed by clinicians and analyzed by commercial labs — with broad implications for people’s ability to get timely covid diagnoses, prevent disease transmission and track the virus.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Overview of how the end of the national Covid emergency will affect Americans
Log in or register to post comments

U.S. FDA approves first RSV vaccine, a long-sought scientific achievement

Wed, 2023-05-03 13:24 — mike kraft

FDA approves first RSV vaccine, a long-sought scientific achievement The FDA has approved the first-ever vaccine for respiratory syncytial virus, or RSV, completing an elusive quest that has been decades in the making. Helen Branswell STAT

... The product, GSK’s Arexvy, was approved for adults ages 60 and older.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. FDA approves first RSV vaccine, a long-sought scientific achievement
Log in or register to post comments

After COVID and drug shortages, EU revamps drug laws

Thu, 2023-04-27 10:09 — mike kraft

Explainer: After COVID and drug shortages, EU revamps drug laws The EU is revamping laws governing the 136 billion euro ($148 billion) pharmaceuticals industry aimed at reviving investment and boosting access to affordable drugs at a time when health budgets have been drained by the costs of treating COVID-19. Maggie Fick Reuters

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about After COVID and drug shortages, EU revamps drug laws
Log in or register to post comments

Increased physical activity associated with lower risk of severe COVID-19 --study

Thu, 2023-04-27 08:47 — mike kraft

Increased physical activity associated with lower risk of severe COVID-19 CIDRAP

A South Korean study shows a complex relationship between moderate to vigorous physical activity (MVPA) and COVID-19, with a regular exercise habit linked to COVID-19 infection early in the pandemic but also associated with a significantly lower risk of developing severe symptoms. The study was published yesterday in JAMA Network Open.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Increased physical activity associated with lower risk of severe COVID-19 --study
Log in or register to post comments

SAB Biotherapeutics Reports Positive Results from COVID Drug SAB-185

Wed, 2023-04-26 10:27 — mike kraft

SAB Biotherapeutics Sees Positive Results from COVID Drug SAB-185 By Exec Edge Editorial Staff SAB Biotherapeutics (Nasdaq: SABS) said it saw positive results from a Phase 3 clinical trial that assessed its Covid-19 drug, SAB-185, in non-hospitalized people who were at high-risk for severe outcomes. SAB-185 demonstrated benefit in sustained symptom resolution in study participants with Covid-19 caused by Omicron as compared to participants […] Yahoo Finance

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about SAB Biotherapeutics Reports Positive Results from COVID Drug SAB-185
Log in or register to post comments

Monoclonal antibodies were highly effective in preventing severe COVID-19 before resistance developed

Wed, 2023-04-26 09:56 — mike kraft

Before resistance developed, monoclonal antibodies were highly effective in preventing severe COVID-19 CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

U.S. COVID Pandemic relief efforts failed to reach many immigrant families

Mon, 2023-04-24 18:08 — mike kraft

Pandemic relief efforts did not reach immigrant families CIDRAP

Immigrant families living in the United States took some of the hardest economic hits during the COVID-19 pandemic, but benefited less from government assistance and relief programs than families with US-born caregivers.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?: